Keyphrases
Adverse Events
20%
Botox
80%
Botox Injection
20%
Botulinum Neurotoxin (BoNT)
100%
Diabetic
100%
Diabetic Neuropathy
20%
Double-blind Randomized Clinical Trial
20%
Forefoot
100%
Forefoot Ulceration
100%
Gastrocnemius
20%
Muscle Injection
20%
Muscle Strength
20%
No Complication
20%
Patients with Diabetes
40%
Peak Plantar Pressure
40%
Peak Torque
60%
Peripheral Neuropathy
100%
Physiological Changes
20%
Placebo
40%
Plantar Flexors
80%
Plantar Pressure
100%
Plantar Ulcer
40%
Soleus muscle
20%
Toxin Effects
100%
Type 1 Diabetes Mellitus (T1DM)
40%
Medicine and Dentistry
Adverse Event
14%
Botulinum Toxin A
100%
Clostridium Botulinum Type A
100%
Diabetes Mellitus
100%
Diabetic Neuropathy
14%
Forefoot
100%
Gastrocnemius
14%
Muscle Strength
14%
Neuropathy
100%
Placebo
28%
Plantar Ulcer
28%
Randomized Clinical Trial
14%
Soleus Muscle
14%
Venous Ulcer
100%
Nursing and Health Professions
Adverse Event
14%
Botulinum Toxin A
100%
Clostridium Botulinum Type A
100%
Diabetes Mellitus
100%
Diabetic Neuropathy
14%
Muscle Strength
14%
Neuropathy
100%
Pilot Study
14%
Placebo
28%
Plantar Ulcer
28%
Ulcer
100%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
14%
Botulinum Toxin A
100%
Clostridium Botulinum Type A
100%
Diabetes Mellitus
100%
Diabetic Neuropathy
14%
Neuropathy
100%
Placebo
28%
Plantar Ulcer
28%
Randomized Clinical Trial
14%
Ulcer
100%